Lactobacillus plantarum CBT-LP3
Lactiplantibacillus plantarum CBT LP3 is a probiotic strain originating from kimchi fermentation, with baseline probiotic characteristics including acid tolerance and epithelial adhesion established in vitro. Animal studies have examined immune responses in the context of colitis and atopic conditions, and it has been explored in combination with other strains for effects on metabolic markers such as insulin resistance and body weight in rodent models. Some animal research has also examined the bioavailability of plant-derived compounds like ginsenosides. Human clinical evidence for this specific strain remains limited, and findings from animal models may not translate directly to people. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 9 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 5 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
11 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 42649118 →Bifidobacterium breve CBT BR3 and Lactiplantibacillus plantarum CBT LP3 Alleviate Hepatic Steatosis by Suppressing Hepatic Lipogenesis and Improving Metabolic Hormone Profiles In Vitro and In Vivo· Journal of Microbiology and Biotechnology · 2026